News
2d
PsyPost on MSNPsilocybin shows promise for improving mood, cognition, and motor symptoms in Parkinson’s diseaseA small pilot study has found that psilocybin, the active compound in psychedelic mushrooms, may improve not only mood but ...
Harm caused by repeated concussions, especially in the context of sports, has gained attention in both research and the media ...
Discover how psilocybin therapy could transform Parkinson’s care - read more about this promising pilot trial and future ...
Unsupervised use of psilocybin has risen dramatically among youth and adults 30 and older, along with a corresponding rise in ...
Psilocybin Use Dramatically Increasing In U.S. By Dennis Thompson HealthDay Reporter WEDNESDAY, April 23, 2025 (HealthDay News) — Recreational use of “magic mushroom” psilocybin skyrocketed ...
As science and spirituality collide through psychedelic research, how do we balance rigour with existing difficulty of ...
Denver, Colorado became the first U.S. city to decriminalize psilocybin — a chemical found in “magic mushrooms” — in May of 2019. Since then, usage across the U.S. has bloomed significantly. Often ...
In a pioneering development in Parkinson’s disease research, scientists at the University of California, San Francisco (UCSF) ...
Use of psilocybin has increased among all age groups since some states decriminalized the hallucinogen in 2019.
A new pilot study reveals that psilocybin—the compound found in psychedelic mushrooms—may significantly improve mood, ...
Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found.
WEDNESDAY, April 23, 2025 (HealthDay News) — Recreational use of “magic mushroom” psilocybin skyrocketed in the U.S. during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results